EUVIMEDEUVIMED entdecken
Open Access

Blood‐Brain Barrier‐Penetrating Nanocarriers Enable Microglial‐Specific Drug Delivery in Hypothalamic Neuroinflammation

Yoon Tae Goo, Vladislav Grigoriev, Tetiana Korzun, Kongbrailatpam Shitaljit Sharma, Prem Singh, Olena R Taratula, Daniel L Marks, Oleh Taratula iD

Advanced Healthcare Materials · 2025-05 · 14 (13)

DOI: 10.1002/adhm.202500521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 03.04.2025. Verfasst von Yoon Tae Goo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, Oregon, 97201, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Microglia, Drug Carriers, Hypothalamus. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, National Cancer Institute of the National Institutes of Health, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypothalamic inflammation plays a pivotal role in appetite dysregulation across various pathological conditions, including cancer cachexia. However, delivering anti‐inflammatory agents to microglia, key mediators of hypothalamic inflammation, remains challenging due to the unsurmountable blood‐brain barrier (BBB). To overcome this challenge, dual peptide‐functionalized polymeric nanocarriers capable of both BBB penetration and microglial targeting are engineered for systemic delivery of IRAK4 inhibitors to treat hypothalamic inflammation. After intravenous administration, the nanocarriers demonstrated efficient brain and hypothalamic accumulation in both acute (lipopolysaccharide‐induced) and chronic (pancreatic cancer cachexia) neuroinflammation mouse models. Their microglial targeting capability is confirmed through hypothalamic immunohistochemistry and flow cytometry analysis using a BBB‐microglia co‐culture model. Systemic administration of IRAK4 inhibitor‐loaded nanocarriers effectively attenuated hypothalamic inflammation in both animal models, as evidenced by marked reductions in pro‐inflammatory cytokine expression. Treated animals displayed significantly increased food intake and improved body weight compared to the saline‐treated group. In the cancer cachexia model, the treatment preserved muscle mass, reducing cachexia‐induced gastrocnemius muscle loss by 50% relative to controls. These findings highlight the potential of this nanocarrier system as a promising therapeutic strategy for conditions characterized by hypothalamic dysfunction, particularly cancer cachexia, where neuroinflammation plays a crucial role in disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierMicrogliaDrug CarriersHypothalamusNanoparticlesNeuroinflammatory DiseasesDrug Delivery SystemsAnimalsMiceMaleCachexiaLipopolysaccharidesMice, Inbred C57BLInflammationDisease Models, Animal

Stichwörter der Autor:innen

IRAK4 inhibitorbrain‐targeting nanocarriercachexiahypothalamic inflammationmicroglia

Substanzen

Drug CarriersLipopolysaccharides

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, Oregon, 97201, USA.
  • Endevica Bio, 1935 Techny Rd, Northbrook, Illinois, 60062, USA.

ORCID-Profile: Oleh Taratula

Förderung

  • NICHD NIH HHS
  • National Cancer Institute of the National Institutes of Health
  • National Research Foundation of Korea
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • NCI NIH HHS

Zitieren

APA

Goo, Y. T., Grigoriev, V., Korzun, T., Sharma, K. S., Singh, P., Taratula, O. R., Marks, D. L., & Taratula, O. (2025). Blood‐Brain Barrier‐Penetrating Nanocarriers Enable Microglial‐Specific Drug Delivery in Hypothalamic Neuroinflammation. Advanced Healthcare Materials, 14(13). https://doi.org/10.1002/adhm.202500521

Vancouver

Goo YT, Grigoriev V, Korzun T, Sharma KS, Singh P, Taratula OR, et al. Blood‐Brain Barrier‐Penetrating Nanocarriers Enable Microglial‐Specific Drug Delivery in Hypothalamic Neuroinflammation. Advanced Healthcare Materials. 2025;14(13). doi:10.1002/adhm.202500521

BibTeX
@article{Goo2025,
  author = {Goo, Yoon Tae and Grigoriev, Vladislav and Korzun, Tetiana and Sharma, Kongbrailatpam Shitaljit and Singh, Prem and Taratula, Olena R and Marks, Daniel L and Taratula, Oleh},
  title = {Blood‐Brain Barrier‐Penetrating Nanocarriers Enable Microglial‐Specific Drug Delivery in Hypothalamic Neuroinflammation},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {13},
  doi = {10.1002/adhm.202500521}
}
Kostenlos starten →